1.
Effectiveness and safety of oral HIV preexposure prophylaxis for all populations
by Fonner, Virginia A
AIDS (London), 2016, Vol.30 (12), p.1973-1983
2.
Rescuing the bottom billion through control of neglected tropical diseases
by Hotez, Peter J, Prof
The Lancet (British edition), 2009, Vol.373 (9674), p.1570-1575
3.
Sexually transmitted infections: challenges ahead
by Unemo, Magnus
The Lancet infectious diseases, 2017, Vol.17 (8), p.e235-e279
4.
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
by Chen, Hsiao-Ping
Gut, 2013, Vol.62 (4), p.606-615
5.
Prevention of malaria in pregnancy
by Desai, Meghna
The Lancet infectious diseases, 2018, Vol.18 (4), p.e119-e132
6.
Acceptability and use of a dapivirine vaginal ring in a phase III trial
by Montgomery, Elizabeth T
AIDS (London), 2017, Vol.31 (8), p.1159-1167
7.
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
by Solomon, Marc M
AIDS (London), 2014, Vol.28 (6), p.851-859
8.
Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial
by Marty, Francisco M, Dr
The Lancet infectious diseases, 2011, Vol.11 (4), p.284-292
9.
Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis
by Fagarasanu, Andrei
Annals of surgical oncology, 2016, Vol.23 (5), p.1422-1430
10.
Strategies for thromboprophylaxis in Fontan circulation: a meta-analysis
by Alsaied, Tarek
Heart (British Cardiac Society), 2015, Vol.101 (21), p.1731-1737
11.
Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
by Zhang, Zhi-Jiang
The journal of clinical endocrinology and metabolism, 2012, Vol.97 (7), p.2347-2353
12.
Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria
by Mitchell, Kate M
AIDS (London), 2015, Vol.29 (15), p.2035-2044
13.
Chemoprevention Uptake for Breast Cancer Risk Reduction Varies by Risk Factor
by Flanagan, Meghan R
Annals of surgical oncology, 2019, Vol.26 (7), p.2127-2135
14.
Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study
by Zelenev, Alexei
The Lancet infectious diseases, 2018, Vol.18 (2), p.215-224
15.
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
by Eckman, Mark H
The American heart journal, 2016, Vol.176, p.17-27
16.
The expanding role of co-trimoxazole in developing countries
by Church, James A, MB
The Lancet infectious diseases, 2015, Vol.15 (3), p.327-339
17.
Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention
by Hecht, Stephen S
The lancet oncology, 2002, Vol.3 (8), p.461-469
18.
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs
by Wang, J.-F
European journal of clinical microbiology & infectious diseases, 2014, Vol.34 (4), p.651-659
19.
Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial
by MURNANE, Pamela M
AIDS (London), 2013, Vol.27 (13), p.2155-2160
20.
Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study
by Lerolle, N
Clinical microbiology and infection, 2014, Vol.20 (11), p.O952-O959
